Related references
Note: Only part of the references are listed.The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
Yariv Mazor et al.
SCIENTIFIC REPORTS (2017)
Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies
Yashas Rajendra et al.
BIOTECHNOLOGY PROGRESS (2017)
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
Eugene A. Zhukovsky et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Comparing domain interactions within antibody Fabs with kappa and lambda light chains
Raheleh Toughiri et al.
MABS (2016)
Despite slow progress, bispecifics generate buzz
Cormac Sheridan
NATURE BIOTECHNOLOGY (2016)
Computationally Designed Bispecific Antibodies using Negative State Repertoires
Andrew Leaver-Fay et al.
STRUCTURE (2016)
Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
Ji-Hee Ha et al.
FRONTIERS IN IMMUNOLOGY (2016)
A High Cell Density Transient Transfection System for Therapeutic Protein Expression Based on a CHO GS-Knockout Cell Line: Process Development and Product Quality Assessment
Yashas Rajendra et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Transcriptional and post-transcriptional targeting for enhanced transient gene expression in CHO cells
Yashas Rajendra et al.
BIOTECHNOLOGY LETTERS (2015)
Enhanced Plasmid DNA Utilization in Transiently Transfected CHO-DG44 Cells in the Presence of Polar Solvents
Yashas Rajendra et al.
BIOTECHNOLOGY PROGRESS (2015)
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic NanobodyA® targeting the DR5 receptor
Kyriakos P. Papadopoulos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Bispecific antibodies
Roland E. Kontermann et al.
DRUG DISCOVERY TODAY (2015)
A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
Zhi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Combined Covalent-Electrostatic Model of Hydrogen Bonding Improves Structure Prediction with Rosetta
Matthew J. O'Meara et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
Xiufeng Wu et al.
MABS (2015)
Improving target cell specificity using a novel monovalent bispecific IgG design
Yariv Mazor et al.
MABS (2015)
Alternative molecular formats and therapeutic applications for bispecific antibodies
Christoph Spiess et al.
MOLECULAR IMMUNOLOGY (2015)
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
Nicolas Fischer et al.
NATURE COMMUNICATIONS (2015)
Antiparallel Conformation of Knob and Hole Aglycosylated Half-Antibody Homodimers Is Mediated by a CH2-CH3 Hydrophobic Interaction
J. Michael Elliott et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M. Lewis et al.
NATURE BIOTECHNOLOGY (2014)
Autoantibodies to Variable Heavy (VH) Chain Ig Sequences in Humans Impact the Safety and Clinical Pharmacology of a VH Domain Antibody Antagonist of TNF-α Receptor 1
M. C. Holland et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Improving biophysical properties of a bispecific antibody scaffold to aid developability Quality by molecular design
Thomas Spreter Von Kreudenstein et al.
MABS (2013)
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
Christoph Spiess et al.
NATURE BIOTECHNOLOGY (2013)
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Aran F. Labrijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
Pavel Strop et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
Christian Klein et al.
MABS (2012)
Targeting T Cells with Bispecific Antibodies for Cancer Therapy
Lawrence G. Lum et al.
BIODRUGS (2011)
Alternate States of Proteins Revealed by Detailed Energy Landscape Mapping
Michael D. Tyka et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Anchored Design of Protein-Protein Interfaces
Steven M. Lewis et al.
PLOS ONE (2011)
A Generic Program for Multistate Protein Design
Andrew Leaver-Fay et al.
PLOS ONE (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of conformational sampling in computing mutation-induced changes in protein structure and stability
Elizabeth H. Kellogg et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO
Adam Doern et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies
Matthias J. Feige et al.
MOLECULAR CELL (2009)
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
Jennifer S. Michaelson et al.
MABS (2009)
Bispecific antibodies for cancer therapy The light at the end of the tunnel?
Patrick Chames et al.
MABS (2009)
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Aran F. Labrijn et al.
NATURE BIOTECHNOLOGY (2009)
Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
Jacob L. Jordan et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization
Judith Schmiedel et al.
CANCER CELL (2008)
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival
Hongkui Jin et al.
CANCER RESEARCH (2008)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Suppression of sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample preparation artifacts for analysis of IgG4 half-antibody
FR Taylor et al.
ANALYTICAL BIOCHEMISTRY (2006)
Domain interactions in the Fab fragment:: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability
D Röthlisberger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells
R Nahta et al.
CANCER RESEARCH (2004)
Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations
JJ Gray et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Share Paper
